Sanofi and Regeneron ' s Dupixent Wins New European Commission Approval Sanofi and Regeneron ' s Dupixent Wins New European Commission Approval

Sanofi and Regeneron said on Monday that their Dupixent product had won approval from the European Commission to treat eosinophilic esophagitis.Reuters Health Information
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Gastroenterology News Source Type: news